ÉèΪÊ×Ò³ ¼ÓÈëÊÕ²Ø

TOP

Digoxin Tablets 100¡Á0.0625£¨µØ¸ßÐÁƬ¡¸KYO¡¹¥¸¥´¥­¥·¥óåV£©
Ò©µê¹ú±ð£º  
²úµØ¹ú¼Ò£º ÈÕ±¾ 
´¦ ·½ Ò©£º ÊÇ 
ËùÊôÀà±ð£º 0.0625ºÁ¿Ë/Ƭ 100Ƭ/ºÐ 
°ü×°¹æ¸ñ£º 0.0625ºÁ¿Ë/Ƭ 100Ƭ/ºÐ 
¼Æ¼Ûµ¥Î»£º ºÐ 
Éú²ú³§¼ÒÖÐÎIJο¼ÒëÃû:
°²Ë¹Ì©À´ÖÆÒ©
Éú²ú³§¼ÒÓ¢ÎÄÃû:
Astellas Pharma Inc.
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·1:
http://www.info.pmda.go.jp/go/pack/2113003F1065_1_14/
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·2:
¸ÃÒ©Æ·Ïà¹ØÐÅÏ¢ÍøÖ·3:
Ô­²úµØÓ¢ÎÄÉÌÆ·Ãû:
Digoxin£¨¥¸¥´¥­¥·¥óåV¡¸KYO¡¹£©0.0625mg/Tablets 100Tablets/box
Ô­²úµØÓ¢ÎÄÒ©Æ·Ãû:
Digoxin
ÖÐÎIJο¼ÉÌÆ·ÒëÃû:
Digoxin£¨¥¸¥´¥­¥·¥óåV¡¸KYO¡¹£©0.0625ºÁ¿Ë/Ƭ 100Ƭ/ºÐ
ÖÐÎIJο¼Ò©Æ·ÒëÃû:
µØ¸ßÐÁ
ÔøÓÃÃû:
¼ò½é£º

 

²¿·ÝÖÐÎĵظßÐÁ´¦·½×ÊÁÏ£¨½ö¹©²Î¿¼£©
ÉÌÆ·Ãû£ºDigoxin Tablets
Ó¢ÎÄÃû£ºDigoxin
ÖÐÎÄÃû£ºµØ¸ßÐÁƬ
Éú²úÉÌ£º°²Ë¹Ì©À´ÖÆÒ©
Ò©Æ·¼ò½é
Digoxin£¨¥¸¥´¥­¥·¥óåV£¬µØ¸ßÐÁ£©ÊÇÒ»ÖÖ¡¸ÐÄÔಡҩ¡¹£¬ÆäÖ÷Òª×÷Óã¬ÐÄÔàÇ¿»¯¡¢ÐÄÔàÊÕËõÄÜÁ¦¡¢ÐÄÔàÇ¿»¯¡¢ÐÄÔàÊÕËõ¡¢ÊÕËõѪÁ÷Á¿ºÍ¹ý¶ÈË®ºÏÒýÆðµÄÐÄÁ¦Ë¥½ß¡£
¥¸¥´¥­¥·¥óåV0.0625¡¸KYO¡¹/¥Ï©`¥Õ¥¸¥´¥­¥·¥óKYåV0.125/¥¸¥´¥­¥·¥óKYåV0.25
ҩЧ·ÖÀàÃû³Æ
ÑóµØ»ÆÜÕÖƼÁ
Åú×¼ÈÕÆÚ£º2015Äê1ÔÂ
É̘ËÃû
Digoxin Tablets 0.0625¡¸KYO¡¹
Halfdigoxin-KY Tablets 0.125
Digoxin-KY Tablets 0.25
Ò»°ãµÄÃû³Æ
¥¸¥´¥­¥·¥ó£¨Digoxin£©
»¯Ñ§Ãû
3β-[2,6-Dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyloxy]-12β,14-dihydroxy-5β,14β-card-20(22)-enolide
·Ö×Óʽ
C41H64O14
·Ö×ÓÁ¿
780.94
ÐÔ×´
µØ¸ßÐÁΪÎÞÉ«ÖÁ°×É«½á¾§»ò°×É«½á¾§·ÛÄ©¡£ËüÒ×ÈÜÓÚßÁण¬Î¢ÈÜÓÚÒÒ´¼£¨95£©£¬¼«Î¢ÈÜÓÚÒÒËᣨ100£©£¬¼¸ºõ²»ÈÜÓÚË®¡£
»¯Ñ§˜‹Ôìʽ
ҩЧҩÀí
×÷ÓûúÖÆ
µØ¸ßÐÁͨ¹ý½áºÏºÍÒÖÖÆÁ×ËữµÄNa+¡¢K+-ATPase αÑÇ»ùÀ´¼õÉÙNa+ÍâÁ÷²¢Ôö¼Óϸ°ûÄÚNa+Ũ¶È¡£Õâ³ÉΪNa+-Ca2+½»»»µÄÇý¶¯Á¦£¬½á¹ûϸ°ûÄÚCa2+Ôö¼Ó£¬Ðļ¡ÊÕËõÁ¦Ôö¼Ó¡£¾Ý˵Ëü»¹¾ßÓÐÐĶ¯¹ý»ººÍ¿¹ÐÄÂÉʧ³£×÷Óá£
ÊÊÓ¦Ö¢
・»ùÓÚÒÔϼ²²¡µÄ³äѪÐÔÐÄÁ¦Ë¥½ß£¨°üÀ¨·ÎË®Öס¢ÐÄÔ´ÐÔÏø´­µÈ£©
ÏÈÌìÐÔÐÄÔಡ¡¢°êĤ²¡¡¢¸ßѪѹ¡¢È±ÑªÐÔÐÄÔಡ£¨Ðļ¡¹£Èû¡¢ÐĽÊÍ´µÈ£©¡¢·ÎÐIJ¡£¨Òò·ÎѪ˨/˨Èû¡¢·Î˨Èû¡¢·ÎÏËά»¯µÈ£©£¬ÒÔ¼°ÆäËûÐÄÔಡ£¨Òò·ÎѪ˨/˨Èû¡¢·Î˨Èû¡¢·ÎÏËά»¯µÈ£©¸¹Ä¤Ñס¢Ðļ¡²¡µÈ£©¡¢Éö²¡¡¢¼×¿ººÍÐĽÊÍ´µÈ¡£
・ÐÄ·¿²ü¶¯/·¿ÆËÒýÆðµÄÐĶ¯¹ýËÙ
・Õó·¢ÐÔÊÒÉÏÐÔÐĶ¯¹ýËÙ
・Ô¤·ÀºÍÖÎÁÆÏÂÁÐÇé¿öϵÄÐÄÁ¦Ë¥½ßºÍ¸÷ÖÖÐĶ¯¹ýËÙ
ÊÖÊõ¡¢¼±ÐÔ·¢ÈÈÐÔ¼²²¡¡¢·ÖÃä¡¢ÐÝ¿Ë¡¢¼±ÐÔÖж¾
Ó÷¨ÓëÓÃÁ¿
・ͨ³£ÓÃÓÚ³ÉÈË×÷ΪµØ¸ßÐÁ
(1)¿ìËÙ±¥ºÍÁÆ·¨£¨±¥ºÍÁ¿£º1.0-4.0mg£©
Ê״οڷþ0.5¡«1.0mg£¬Ö®ºóÿ6¡«8Сʱ¿Ú·þ0.5mg£¬Ö±ÖÁ³öÏÖ³ä·ÖЧ¹û¡£
(2)¿ÉÒÔ½øÐнϿìµÄ±¥ºÍÖÎÁÆ¡£
(3)¿ÉÒÔ½øÐÐÂý±¥ºÍÁÆ·¨¡£
(4)ά³ÖÖÎÁÆ
ÿÌì¿Ú·þ0.25ÖÁ0.5ºÁ¿Ë¡£
・ͨ³£ÓÃÓÚ¶ùͯ×÷ΪµØ¸ßÐÁ
(1)¿ìËÙ±¥ºÍÁÆ·¨
2 Ëê»òÒÔÏ£ºÃ¿Ìì0.06ÖÁ0.08ºÁ¿Ë/¹«½ï£¬·Ö3ÖÁ4´Î¿Ú·þ¡£
2 Ëê¼°ÒÔÉÏ£ºÃ¿Ìì¿Ú·þ0.04ÖÁ0.06ºÁ¿Ë/¹«½ï£¬·Ö3ÖÁ4´Î·þÓá£
(2)ά³ÖÖÎÁÆ
・¿Ú·þ¸øÓè±¥ºÍ¼ÁÁ¿µÄ1/5ÖÁ1/3¡£
°ü×°
Ƭ¼Á
0.0625 "KYO"
100Ƭ[10Ƭ(PTP)x10]¡¢100Ƭ[Æ¿¡¢Ãµ¹å]
KYƬ
0.125
100Ƭ[10Ƭ(PTP)×10]¡¢100Ƭ[Æ¿¡¢Ãµ¹å]¡¢1000Ƭ[10Ƭ(PTP)×100]¡¢1400Ƭ[14Ƭ(PTP)×100]
KYƬ0.25
100Ƭ[10Ƭ(PTP)×10]¡¢100Ƭ[Æ¿¡¢Ãµ¹å]¡¢1000Ƭ[10Ƭ(PTP)×100]
ÖÆÔìÉ̺ͷÖÏúÉÌ
¾©¶¼ÖÆÒ©¹¤ÒµÖêʽ»áÉç
ÏúÊÛ
¶«ÑǾ«ÑóÖêʽ»áÉç
ÏúÊÛ
°²Ë¹Ì©À´ÖÆÒ©¹«Ë¾
×¢£ºÒÔÉÏÖÐÎÄ´¦·½×ÊÁϲ»¹»ÍêÕû£¬Ê¹ÓÃÕßÒÔÔ­´¦·½×ÊÁÏΪ׼¡£
ÍêÕû˵Ã÷×ÊÁϸ½¼þ£º
https://www.info.pmda.go.jp/go/pack/2113003F1065_1_15/
------------------------------------------
Digoxin tablets 0.0625[KYO]£¨Digoxin£©
Brand name:Digoxin tablets 0.0625 [KYO]
Active ingredient:Digoxin
Dosage form:white to yellowish white tablet(diameter: 6.0mm, thickness: 2.2 mm)
Print on wrapping:(face) KYO270, ¥¸¥´¥­¥·¥ó¡¸KYO¡¹, 0.0625mg, ¥¸¥®¥¿¥ê¥¹Ñu„ˆ
(back) ¥¸¥´¥­¥·¥ó¡¸KYO¡¹, 0.0625mg, ¥¸¥®¥¿¥ê¥¹Ñu„ˆ
Effects of this medicine
This medicine strengthens myocardial contractile force, slows heart rate, and stabilizes pulse.
It is usually used for the treatment of heart failure and tachycardia.
Before using this medicine, be sure to tell your doctor and pharmacist
・If you have previously experienced any allergic reactions(itch, rash, etc.)to any medicines.
If you have: heart disease, renal dysfunction, hypothyroidism, hyperthyroidism, or an electrolyte abnormality
(including potassium, calcium or magnesium, etc).
If you are a hemodialytic patient.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may interact to enhance or diminish medicinal
effects. Beware of over-the-counter medicines and dietary supplements as well as other prescription medicines.)
Dosing schedule(How to take this medicine)
・Your dosing schedule prescribed by your doctor is<<to be written by a healthcare professional>>
・For adults:In general,as maintenance treatment, take 4 to 8 tablets(0.25 to 0.5 mg of the active ingredient) per day.
[For rapid digitalization, for which the saturation dose with digoxin is 1.0 to 4.0 mg, take 0.5 to 1.0mg initially followed by 0.5 mg every 6to 8 hours until a sufficient response is observed]
For children: In general, as maintenance treatment, give one-fifth to one-third of the saturation dose.[For rapiddigitalization, give 0.06 to 0.08 mg/kg per day for a child 2 years old or younger and 0.04 to 0.06 mg/kg per day for a child 2 years old or older in 3 or 4 divided doses]
Each tablet contains 0.0625 mg of the active ingredient.Strictly follow the instructions.
・If you miss a dose, skip the missed dose and take your next dose at the regular time. You should never take two doses at one time.
・If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
・Do not stop taking this medicine unless your doctor instructs you to do so.
Precautions while taking this medicine
・Due to the variation in optimal dosage of this medicine among individuals, your doctor may change your dose based on your condition. Therefore, contact your doctor routinely.
・DO NOT take health foods containing hypericum perforatum (St.John's Wort); this may weaken the effect of this
medicine by accelerating its metabolism. Consult with your doctor or pharmacist if you have taken such healthfoods.
Possible adverse reactions to this medicine
The most commonly reported adverse reactions include rash,hives, purpura and edema.If any of these symptoms
occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets.If any of these symptoms occur, stop taking this medicine and see your doctorimmediately.
・loss of appetite, vomiting, visual abnormality, confusion, arrhythmia[digitalistoxicity]
・severe abdominal pain, bloody stools[non-occlusive mesenteric ischemia]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with yourdoctor or pharmacist if you notice any symptoms of concern other than those listed above.
Storage conditions and other information
・Keep out of the reach of children. Store away from heat, moisture and light.
・Discard the remainder.Do not store them.Consult with your dispensing pharmacy ormedical institution when you
discard the medicine.
Internal
Published: 01/2015
The information on this sheet is based on approvals granted by the Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions(risks)as well as efficacies (benefits).It is
important to minimize adverse reactions and maximize efficacy.To obtain a better therapeutic response,
patients should understand their medication and cooperate with the treatment.  

¡¾´ó ÖРС¡¿¡¾´òÓ¡¡¿ ¡¾·±Ìå¡¿¡¾Í¶¸å¡¿¡¾Êղء¿ ¡¾ÍƼö¡¿¡¾¾Ù±¨¡¿¡¾ÆÀÂÛ¡¿ ¡¾¹Ø±Õ¡¿ ¡¾·µ»Ø¶¥²¿¡¿
·ÖÏíµ½QQ¿Õ¼ä
·ÖÏíµ½: 
ÉÏһƪ£ºVyndaqel 20mg Capsule molle,2pl.. ÏÂһƪ£ºVyndaqel 20mg C¨¢psulas blandas..

Ïà¹ØÀ¸Ä¿

×îÐÂÎÄÕÂ

ͼƬÖ÷Ìâ

ÈÈÃÅÎÄÕÂ

ÍƼöÎÄÕÂ